Curis (CRIS) Times Interest Earned (2013 - 2025)
Curis (CRIS) reported Times Interest Earned of $62.48 for Q4 2025, up 691.19% on a YoY basis from $7.9 in Q4 2024, and up 898.61% quarter-over-quarter from -$7.82 in Q3 2025.
Curis (CRIS) Times Interest Earned (2013 - 2025) Analysis & Trends
Curis has reported Times Interest Earned for 13 years, with the latest figure at $62.48 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned rose 691.19% year-over-year to $62.48; the trailing twelve-month figure through Mar 2026 stood at -$4.33 (up 87.23% YoY), and the FY2025 full-year result was -$2.61, up 96.39% from the prior year.
- Times Interest Earned for Q4 2025 stood at $62.48, up from -$7.82 in the prior quarter.
- The five-year high for Times Interest Earned was $1564.0 in Q2 2024, with the low at -$68.53 in Q4 2023.
- Historically, Times Interest Earned has averaged $79.42 across 5 years, with a median of -$10.97 in 2021.
- Annual changes were most pronounced in 2023 — Times Interest Earned sank 1007.13% — and 2024, when it surged 8320.73%.
- Curis' Times Interest Earned stood at -$11.36 in 2021, then jumped by 45.52% to -$6.19 in 2022, then slumped by 1007.13% to -$68.53 in 2023, then surged by 84.58% to -$10.57 in 2024, then soared by 691.19% to $62.48 in 2025.
- The last three Times Interest Earned figures came in at $62.48 (Q4 2025), -$7.82 (Q3 2025), and -$19.01 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -258.33 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 11.79 |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62.48 |
| Sep 30, 2025 | -7.82 |
| Jun 30, 2025 | -19.01 |
| Mar 31, 2025 | -18.40 |
| Dec 31, 2024 | -10.57 |
| Sep 30, 2024 | 70.45 |
| Jun 30, 2024 | 1,564.00 |
| Mar 31, 2024 | 159.86 |
| Dec 31, 2023 | -68.53 |
| Sep 30, 2023 | -19.98 |
| Jun 30, 2023 | -19.03 |
| Mar 31, 2023 | -19.91 |
| Dec 31, 2022 | -6.19 |
| Sep 30, 2022 | -12.32 |
| Jun 30, 2022 | -14.47 |
| Mar 31, 2022 | -14.33 |
| Dec 31, 2021 | -11.36 |
| Sep 30, 2021 | -9.51 |
| Jun 30, 2021 | -9.38 |
| Mar 31, 2021 | -7.50 |